glp-1 eligibility criteria If you're covered by the State Health Benefit Plan (SHBP) and take a weight-loss medication (like Wegovy or Zepbound), a change is coming. Starting February 1, 2026, SHBP will require these Navigating Changes to GLP-1 Medication

*The actual offer, including the compensation package, will be within the posted range for the relevant zone and will be determined based on multiple factors, such as the candidate's skills and experience, and other business considerations such as internal equity

Several generic GLP-1s are expected on the market in Canada later this year

G.ReihaniH.BagherianF

Separate the two medications by as many hours as possible

Distinguished by its unique triple agonist mechanism, retatrutide targets the glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon (GCG) receptors simultaneously